世界の抗核抗体（ANA）検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anti-nuclear Antibody (ANA) Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5081 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、抗核抗体（ANA）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（間接蛍光抗体法、酵素免疫測定法（ELISA）、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・抗核抗体（ANA）検査の市場動向 ・企業の競争状況、市場シェア ・抗核抗体（ANA）検査の種類別市場規模と予測2016-2027（間接蛍光抗体法、酵素免疫測定法（ELISA）、その他） ・抗核抗体（ANA）検査の用途別市場規模と予測2016-2027（病院、診療所、その他） ・抗核抗体（ANA）検査の北米市場規模2016-2027（アメリカ、カナダ） ・抗核抗体（ANA）検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗核抗体（ANA）検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗核抗体（ANA）検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗核抗体（ANA）検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abcam、Antibodies、Bio-Rad Laboratories、Alere、Erba Diagnostics、MBL International、Merck、Indur Services、Trinity Biotech、Thermo Fisher Scientific、Zeus Scientific） ・結論

Antinuclear antibodies (ANA) are a group of autoantibodies produced by a person’s immune system when it fails to adequately distinguish between “self” and “nonself.” The ANA testing detects these autoantibodies in the blood.

Market Analysis and Insights: Global Anti-nuclear Antibody (ANA) Testing Market
The global Anti-nuclear Antibody (ANA) Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-nuclear Antibody (ANA) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-nuclear Antibody (ANA) Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-nuclear Antibody (ANA) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-nuclear Antibody (ANA) Testing market.

Global Anti-nuclear Antibody (ANA) Testing Scope and Market Size
Anti-nuclear Antibody (ANA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-nuclear Antibody (ANA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Indirect Immunofluorescence
Enzyme-linked Immunosorbent Assay (ELISA)
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abcam
Antibodies
Bio-Rad Laboratories
Alere
Erba Diagnostics
MBL International
Merck
Indur Services
Trinity Biotech
Thermo Fisher Scientific
Zeus Scientific

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Indirect Immunofluorescence
1.2.3 Enzyme-linked Immunosorbent Assay (ELISA)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Anti-nuclear Antibody (ANA) Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-nuclear Antibody (ANA) Testing Market Perspective (2016-2027)
2.2 Anti-nuclear Antibody (ANA) Testing Growth Trends by Regions
2.2.1 Anti-nuclear Antibody (ANA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-nuclear Antibody (ANA) Testing Historic Market Share by Regions (2016-2021)
2.2.3 Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Regions (2022-2027)
2.3 Anti-nuclear Antibody (ANA) Testing Industry Dynamic
2.3.1 Anti-nuclear Antibody (ANA) Testing Market Trends
2.3.2 Anti-nuclear Antibody (ANA) Testing Market Drivers
2.3.3 Anti-nuclear Antibody (ANA) Testing Market Challenges
2.3.4 Anti-nuclear Antibody (ANA) Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue
3.1.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue (2016-2021)
3.1.2 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Players (2016-2021)
3.2 Global Anti-nuclear Antibody (ANA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-nuclear Antibody (ANA) Testing Revenue
3.4 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio
3.4.1 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-nuclear Antibody (ANA) Testing Revenue in 2020
3.5 Anti-nuclear Antibody (ANA) Testing Key Players Head office and Area Served
3.6 Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service
3.7 Date of Enter into Anti-nuclear Antibody (ANA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Type
4.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Type (2016-2021)
4.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2022-2027)

5 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Application
5.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Application (2016-2021)
5.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027)
6.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type
6.2.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021)
6.2.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027)
6.2.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027)
6.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application
6.3.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021)
6.3.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027)
6.3.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027)
6.4 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country
6.4.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021)
6.4.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027)
7.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type
7.2.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021)
7.2.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027)
7.2.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027)
7.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application
7.3.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021)
7.3.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027)
7.3.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027)
7.4 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country
7.4.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021)
7.4.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027)
8.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type
8.2.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application
8.3.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region
8.4.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027)
9.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type
9.2.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021)
9.2.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027)
9.2.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027)
9.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application
9.3.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021)
9.3.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027)
9.3.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027)
9.4 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country
9.4.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021)
9.4.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027)
10.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type
10.2.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application
10.3.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country
10.4.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Anti-nuclear Antibody (ANA) Testing Introduction
11.1.4 Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.1.5 Abcam Recent Development
11.2 Antibodies
11.2.1 Antibodies Company Details
11.2.2 Antibodies Business Overview
11.2.3 Antibodies Anti-nuclear Antibody (ANA) Testing Introduction
11.2.4 Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.2.5 Antibodies Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Alere
11.4.1 Alere Company Details
11.4.2 Alere Business Overview
11.4.3 Alere Anti-nuclear Antibody (ANA) Testing Introduction
11.4.4 Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.4.5 Alere Recent Development
11.5 Erba Diagnostics
11.5.1 Erba Diagnostics Company Details
11.5.2 Erba Diagnostics Business Overview
11.5.3 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Introduction
11.5.4 Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.5.5 Erba Diagnostics Recent Development
11.6 MBL International
11.6.1 MBL International Company Details
11.6.2 MBL International Business Overview
11.6.3 MBL International Anti-nuclear Antibody (ANA) Testing Introduction
11.6.4 MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.6.5 MBL International Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Anti-nuclear Antibody (ANA) Testing Introduction
11.7.4 Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Indur Services
11.8.1 Indur Services Company Details
11.8.2 Indur Services Business Overview
11.8.3 Indur Services Anti-nuclear Antibody (ANA) Testing Introduction
11.8.4 Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.8.5 Indur Services Recent Development
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Details
11.9.2 Trinity Biotech Business Overview
11.9.3 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Introduction
11.9.4 Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.9.5 Trinity Biotech Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Introduction
11.10.4 Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Zeus Scientific
11.11.1 Zeus Scientific Company Details
11.11.2 Zeus Scientific Business Overview
11.11.3 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Introduction
11.11.4 Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
11.11.5 Zeus Scientific Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Indirect Immunofluorescence
Table 3. Key Players of Enzyme-linked Immunosorbent Assay (ELISA)
Table 4. Key Players of Other
Table 5. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-nuclear Antibody (ANA) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-nuclear Antibody (ANA) Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2016-2021)
Table 9. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2022-2027)
Table 11. Anti-nuclear Antibody (ANA) Testing Market Trends
Table 12. Anti-nuclear Antibody (ANA) Testing Market Drivers
Table 13. Anti-nuclear Antibody (ANA) Testing Market Challenges
Table 14. Anti-nuclear Antibody (ANA) Testing Market Restraints
Table 15. Global Anti-nuclear Antibody (ANA) Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players (2016-2021)
Table 17. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2020)
Table 18. Ranking of Global Top Anti-nuclear Antibody (ANA) Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service
Table 22. Date of Enter into Anti-nuclear Antibody (ANA) Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti-nuclear Antibody (ANA) Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abcam Company Details
Table 63. Abcam Business Overview
Table 64. Abcam Anti-nuclear Antibody (ANA) Testing Product
Table 65. Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 66. Abcam Recent Development
Table 67. Antibodies Company Details
Table 68. Antibodies Business Overview
Table 69. Antibodies Anti-nuclear Antibody (ANA) Testing Product
Table 70. Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 71. Antibodies Recent Development
Table 72. Bio-Rad Laboratories Company Details
Table 73. Bio-Rad Laboratories Business Overview
Table 74. Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Product
Table 75. Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 76. Bio-Rad Laboratories Recent Development
Table 77. Alere Company Details
Table 78. Alere Business Overview
Table 79. Alere Anti-nuclear Antibody (ANA) Testing Product
Table 80. Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 81. Alere Recent Development
Table 82. Erba Diagnostics Company Details
Table 83. Erba Diagnostics Business Overview
Table 84. Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Product
Table 85. Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 86. Erba Diagnostics Recent Development
Table 87. MBL International Company Details
Table 88. MBL International Business Overview
Table 89. MBL International Anti-nuclear Antibody (ANA) Testing Product
Table 90. MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 91. MBL International Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Anti-nuclear Antibody (ANA) Testing Product
Table 95. Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Indur Services Company Details
Table 98. Indur Services Business Overview
Table 99. Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 100. Indur Services Recent Development
Table 101. Trinity Biotech Company Details
Table 102. Trinity Biotech Business Overview
Table 103. Trinity Biotech Anti-nuclear Antibody (ANA) Testing Product
Table 104. Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 105. Trinity Biotech Recent Development
Table 106. Thermo Fisher Scientific Company Details
Table 107. Thermo Fisher Scientific Business Overview
Table 108. Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Product
Table 109. Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 110. Thermo Fisher Scientific Recent Development
Table 111. Zeus Scientific Company Details
Table 112. Zeus Scientific Business Overview
Table 113. Zeus Scientific Anti-nuclear Antibody (ANA) Testing Product
Table 114. Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million)
Table 115. Zeus Scientific Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-nuclear Antibody (ANA) Testing Market Share by Type: 2020 VS 2027
Figure 2. Indirect Immunofluorescence Features
Figure 3. Enzyme-linked Immunosorbent Assay (ELISA) Features
Figure 4. Other Features
Figure 5. Global Anti-nuclear Antibody (ANA) Testing Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Anti-nuclear Antibody (ANA) Testing Report Years Considered
Figure 10. Global Anti-nuclear Antibody (ANA) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Anti-nuclear Antibody (ANA) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2022-2027)
Figure 14. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players in 2020
Figure 15. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue in 2020
Figure 17. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027)
Figure 21. North America Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027)
Figure 22. North America Anti-nuclear Antibody (ANA) Testing Market Share by Country (2016-2027)
Figure 23. United States Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027)
Figure 27. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027)
Figure 28. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Country (2016-2027)
Figure 29. Germany Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Region (2016-2027)
Figure 39. China Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027)
Figure 47. Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027)
Figure 48. Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Country (2016-2027)
Figure 49. Mexico Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Country (2016-2027)
Figure 55. Turkey Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abcam Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 59. Antibodies Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 61. Alere Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 62. Erba Diagnostics Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 63. MBL International Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 65. Indur Services Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 66. Trinity Biotech Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 68. Zeus Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---